Publicaciones en colaboración con investigadores/as de Centro de Investigación Médica Aplicada (53)

2024

  1. Transcriptomic Analysis of Extracellular Vesicles in the Search for Novel Plasma and Thrombus Biomarkers of Ischemic Stroke Etiologies

    International journal of molecular sciences, Vol. 25, Núm. 8

2023

  1. Role of LCN2 in a murine model of hindlimb ischemia and in peripheral artery disease patients, and its potential regulation by miR-138-5P

    Atherosclerosis, Vol. 385

2022

  1. Lipocalin-2 and Calprotectin Potential Prognosis Biomarkers in Peripheral Arterial Disease

    European Journal of Vascular and Endovascular Surgery, Vol. 63, Núm. 4, pp. 648-656

  2. Matrix Metalloproteinase 10 Contributes to Choroidal Neovascularisation

    Biomedicines, Vol. 10, Núm. 7

2021

  1. Inner ear drug delivery through a cochlear implant: Pharmacokinetics in a Macaque experimental model

    Hearing Research, Vol. 404

  2. Validation of a rapid antigen test as a screening tool for SARS-CoV-2 infection in asymptomatic populations. Sensitivity, specificity and predictive values

    eClinicalMedicine, Vol. 37

2020

  1. A Role for MMP-10 (Matrix Metalloproteinase-10) in Calcific Aortic Valve Stenosis

    Arteriosclerosis, Thrombosis, and Vascular Biology, Vol. 40, Núm. 5, pp. 1370-1382

  2. A genetic risk score predicts recurrent events after myocardial infarction in young adults

    Revista Espanola de Cardiologia, Vol. 73, Núm. 8, pp. 623-631

  3. Circulating TIMP-1 is associated with hematoma volume in patients with spontaneous intracranial hemorrhage

    Scientific Reports, Vol. 10, Núm. 1

  4. Elevated circulating metalloproteinase 7 predicts recurrent cardiovascular events in patients with carotid stenosis: A prospective cohort study

    BMC Cardiovascular Disorders, Vol. 20, Núm. 1

  5. MMP-10 is Increased in Early Stage Diabetic Kidney Disease and can be Reduced by Renin-Angiotensin System Blockade

    Scientific Reports, Vol. 10, Núm. 1

2019

  1. Analysis of monocitary subpopulations in relation to cardiovascular risk factors

    Clinica e Investigacion en Arteriosclerosis, Vol. 31, Núm. 4, pp. 152-159

  2. High serum levels of tissue inhibitor of matrix metalloproteinase-1 during the first week of a malignant middle cerebral artery infarction in non-surviving patients

    BMC neurology, Vol. 19, Núm. 1, pp. 167

  3. MMP10 Promotes Efficient Thrombolysis After Ischemic Stroke in Mice with Induced Diabetes

    Translational Stroke Research, Vol. 10, Núm. 4, pp. 389-401

  4. Persistently high circulating tissue inhibitor of matrix metalloproteinase-1 levels in non-survivor brain trauma injury patients

    Journal of Critical Care, Vol. 51, pp. 117-121

2018

  1. Matrix metalloproteinase-10 deficiency delays atherosclerosis progression and plaque calcification

    Atherosclerosis, Vol. 278, pp. 124-134

  2. Phenotypic Screening to Discover Novel Chemical Series as Efficient Antihemorrhagic Agents

    ACS Medicinal Chemistry Letters, Vol. 9, Núm. 5, pp. 428-433

  3. Selective increase of cardiomyocyte derived extracellular vesicles after experimental myocardial infarction and functional effects on the endothelium

    Thrombosis Research, Vol. 170, pp. 1-9

2017

  1. CM352 reduces brain damage and improves functional recovery in a rat model of intracerebral hemorrhage

    Journal of the American Heart Association, Vol. 6, Núm. 6

  2. Reduced high-density lipoprotein cholesterol: A valuable, independent prognostic marker in peripheral arterial disease

    Journal of Vascular Surgery, Vol. 66, Núm. 5, pp. 1527-1533.e1